Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size.

Abstract

There is no consensus regarding the optimal dose of stem cells or the optimal route of administration for the treatment of acute myocardial infarction. Bone marrow cells, containing hematopoietic and mesenchymal stem cells, in doses of 0.5 x 10(6) to >30 x 10(6) have been directly injected into the myocardium or into coronary arteries or infused… (More)

Topics

  • Presentations referencing similar topics